JAY-CHRISTIAN PAUL HELT PHARMD
Prescription History 1316639909
Pharmacist in Winchendon, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JAY-CHRISTIAN PAUL HELT PHARMD, an active Pharmacist specialist practicing in Winchendon, MA. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 36 documented patient claims. Among these therapy options, the most frequently utilized medication is Arexvy, which accounts for 24 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| ArexvyRsvpref3 Antigen/As01e/Pf | 24 | $313.67 | ▼ Less than typical |
About Arexvy: This vaccine is used to prevent infection by the respiratory syncytial virus (RSV). Show more ▾ Some brands may also be given during the third trimester of pregnancy to help prevent RSV in the newborn baby. RSV can cause serious illness, especially in older adults with certain health problems (such as heart disease, lung disease) and infants. It works by causing the body to produce its own protection (antibodies) against the virus. Vaccines may not fully protect everyone who receives them. In 2024, this provider wrote 24 Medicare prescriptions for Arexvy, about 8% of the volume of the typical Massachusetts prescriber of this medication (300.4). Medicare paid an average of $313.67 per fill, versus $281.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 24 Days of Medication total across all patients in 2024 | |||
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 12 | $318.32 | ▼ Less than typical |
About Abrysvo: This vaccine is used to prevent infection by the respiratory syncytial virus (RSV). Show more ▾ Some brands may also be given during the third trimester of pregnancy to help prevent RSV in the newborn baby. RSV can cause serious illness, especially in older adults with certain health problems (such as heart disease, lung disease) and infants. It works by causing the body to produce its own protection (antibodies) against the virus. Vaccines may not fully protect everyone who receives them. In 2024, this provider wrote 12 Medicare prescriptions for Abrysvo, about 8% of the volume of the typical Massachusetts prescriber of this medication (158.7). Medicare paid an average of $318.32 per fill, versus $289.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 12 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for JAY-CHRISTIAN PAUL HELT PHARMD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pharmacist prescribing approach at this Winchendon, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
